ACCOUNTS - Final Accounts preparation

Analysis of the maturity of loans is given below:

Registered number: 11872632

EAR HEALTHY LTD

UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2025


EAR HEALTHY LTD

COMPANY INFORMATION

Director	S L Tyndall


Registered number	11872632


Registered office	5 Elstree Gate
	Elstree Way
	Borehamwood
	Hertfordshire
	WD6 1JD


Accountants	Sopher + Co LLP
	Chartered Accountants
	5 Elstree Gate
	Elstree Way
	Borehamwood
	Hertfordshire
	WD6 1JD


EAR HEALTHY LTD

CONTENTS

	Page
Statement of Financial Position	1 - 2
Notes to the Financial Statements	3 - 7


EAR HEALTHY LTD REGISTERED NUMBER:11872632

STATEMENT OF FINANCIAL POSITION

AS AT 31 MARCH 2025

		2025		2024
Note		£		£

Fixed assets
Tangible assets	4		6,839		743
Current assets
Stocks		165		175
Debtors: amounts falling due within one year	5	154		154
Cash at bank and in hand		1,482		1,681
Current liabilities		1,801		2,010
Creditors: amounts falling due within one year	6	(11,649)		(6,163)
Net current liabilities			(9,848)		(4,153)
Creditors: amounts falling due after more than one year			(2,472)		-

Net liabilities			(5,481)		(3,410)

Capital and reserves
Called up share capital	1	1
Profit and loss account	(5,482)	(3,411)
	(5,481)	(3,410)

Page 1


EAR HEALTHY LTD REGISTERED NUMBER:11872632

STATEMENT OF FINANCIAL POSITION (CONTINUED)

AS AT 31 MARCH 2025

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by:

S L Tyndall

Director

Date: 8 October 2025

The notes on pages 3 to 7 form part of these financial statements.

Page 2


EAR HEALTHY LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

1.	General information

Ear Healthy Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 5 Elstree Gate, Elstree Way, Borehamwood, Hertfordshire, United Kingdom, WD6 1JD.
The principal activity of the company contiuned to be that of providing medical audiology.
The functional and presentational currency of the company is £ Sterling.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

2.2

Turnover

Turnover represents net invoiced sales of goods and services excluding value added tax. Income is
recognised at the point the good and service are provided.

2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

2.5

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

2.6

Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their lives on the following bases:

Depreciation is provided on the following basis:

				Plant and machinery	-	25%	reducing balance
				Computer equipment	-	33%	on cost

Page 3


EAR HEALTHY LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

2.10

Financial instruments

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Page 4


EAR HEALTHY LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

2.10

Financial instruments (continued)

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Employees

The average monthly number of employees, including directors, during the year was 1 (2024 - 1).

4.	Tangible fixed assets

	Plant and machinery	Computer equipment	Total
	£	£	£
Cost
At 1 April 2024	2,349	1,204	3,553
Additions	7,607	864	8,471
At 31 March 2025	9,956	2,068	12,024
Depreciation
At 1 April 2024	1,606	1,204	2,810
Charge for the year on owned assets	2,087	288	2,375
At 31 March 2025	3,693	1,492	5,185
Net book value
At 31 March 2025	6,263	576	6,839
At 31 March 2024	743	-	743

Page 5


EAR HEALTHY LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

Debtors

					2025	2024
					£	£

	Prepayments and accrued income	154	154

6.	Creditors: Amounts falling due within one year
		2025	2024
		£	£

Other loans	4,587	-
Corporation tax	-	100
Other creditors	7,062	6,063
	11,649	6,163

7.	Creditors: Amounts falling due after more than one year
		2025	2024
		£	£

	Other loans	2,472	-

Amounts falling due within one year
Other loans	4,587	-
Amounts falling due 1-2 years
Other loans	2,472	-
	7,059	-

The secured loan above has been granted by Oticon Ltd for an initial period of 24 months.
The loan is secured by personal guarantee provided by the Company's director, and is payable in equal installments over the term of the loan. No interest has been charged on the loan.

Page 6


EAR HEALTHY LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

9.	Related party transactions
	Included within other creditors are amounts totalling £7,062 (2024 - £6,063) owed to the director. These amounts are interest free and repayable on demand.

Page 7